سعر باتانيرجيك 1مجم/مل قطرة للعين 5مل 2022

Olopatadine 0.1% (1 mg/ml) ophthalmic solution, 5 ml, by Pharopharma.

• Treatment of the signs and symptoms of allergic conjunctivitis.Population: Adults and children aged 3 years and olderDailyMed (U.S. National Library of Medicine)

• Headache (7%); less than 5%: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperaemia, hypersensitivity, keratitis, lid oedema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, taste perversion.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to olopatadine hydrochloride or any component of the product.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Do not wear contact lenses if the eye is red; not for contact-lens-related irritation. Benzalkonium chloride (preservative in the US product) may be absorbed by soft lenses: wait at least 10 minutes after instillation before inserting them.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Not teratogenic in rats and rabbits, but very high oral doses reduced live fetuses; no adequate studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Found in rat milk after oral dosing; unknown whether ocular use gives detectable amounts in human milk. Use with caution in nursing mothers.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Olopatadine: Inhibits histamine release from mast cells and is a relatively selective histamine H1-receptor antagonist (US Patanol label).